These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 11689489

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
    Hansson O, Castilho RF, Korhonen L, Lindholm D, Bates GP, Brundin P.
    J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the HdhQ150 knock-in mouse model of Huntington's disease.
    Moffitt H, McPhail GD, Woodman B, Hobbs C, Bates GP.
    PLoS One; 2009 Nov 30; 4(11):e8025. PubMed ID: 19956633
    [Abstract] [Full Text] [Related]

  • 7. A patient-derived cellular model for Huntington's disease reveals phenotypes at clinically relevant CAG lengths.
    Hung CL, Maiuri T, Bowie LE, Gotesman R, Son S, Falcone M, Giordano JV, Gillis T, Mattis V, Lau T, Kwan V, Wheeler V, Schertzer J, Singh K, Truant R.
    Mol Biol Cell; 2018 Nov 15; 29(23):2809-2820. PubMed ID: 30256717
    [Abstract] [Full Text] [Related]

  • 8. Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice.
    Petersén A, Stewénius Y, Björkqvist M, Gisselsson D.
    BMC Cell Biol; 2005 Sep 13; 6():34. PubMed ID: 16159402
    [Abstract] [Full Text] [Related]

  • 9. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ, Glynn D, Leavens W, Zheng Z, Faull RL, Skepper JN, Wight JM.
    Neurobiol Dis; 2009 Mar 13; 33(3):331-41. PubMed ID: 19130884
    [Abstract] [Full Text] [Related]

  • 10. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M, Bichell TJ, Soares BD, Loth MK, McGlothan JS, Mori S, Alikhan FS, Hua K, Coughlin JM, Holt HK, Jetter CS, Pomper MG, Osmand AP, Guilarte TR, Bowman AB.
    J Huntingtons Dis; 2015 Mar 13; 4(1):17-36. PubMed ID: 26333255
    [Abstract] [Full Text] [Related]

  • 11. Transgenic models of Huntington's disease.
    Sathasivam K, Hobbs C, Mangiarini L, Mahal A, Turmaine M, Doherty P, Davies SW, Bates GP.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):963-9. PubMed ID: 10434294
    [Abstract] [Full Text] [Related]

  • 12. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
    Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP.
    Cell; 1996 Nov 01; 87(3):493-506. PubMed ID: 8898202
    [Abstract] [Full Text] [Related]

  • 13. Expression of the Huntington's disease transgene in neural stem cell cultures from R6/2 transgenic mice.
    Chu-LaGraff Q, Kang X, Messer A.
    Brain Res Bull; 1996 Nov 01; 56(3-4):307-12. PubMed ID: 11719265
    [Abstract] [Full Text] [Related]

  • 14. Neuronal aggregates are associated with phenotypic onset in the R6/2 Huntington's disease transgenic mouse.
    Cowin RM, Roscic A, Bui N, Graham D, Paganetti P, Jankowsky JL, Weiss A, Paylor R.
    Behav Brain Res; 2012 Apr 15; 229(2):308-19. PubMed ID: 22306231
    [Abstract] [Full Text] [Related]

  • 15. Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patients.
    Seo H, Kim W, Isacson O.
    Hum Mol Genet; 2008 Oct 15; 17(20):3144-53. PubMed ID: 18640989
    [Abstract] [Full Text] [Related]

  • 16. Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease?
    Squitieri F, Frati L, Ciarmiello A, Lastoria S, Quarrell O.
    Mech Ageing Dev; 2006 Feb 15; 127(2):208-12. PubMed ID: 16274727
    [Abstract] [Full Text] [Related]

  • 17. Towards a transgenic model of Huntington's disease in a non-human primate.
    Yang SH, Cheng PH, Banta H, Piotrowska-Nitsche K, Yang JJ, Cheng EC, Snyder B, Larkin K, Liu J, Orkin J, Fang ZH, Smith Y, Bachevalier J, Zola SM, Li SH, Li XJ, Chan AW.
    Nature; 2008 Jun 12; 453(7197):921-4. PubMed ID: 18488016
    [Abstract] [Full Text] [Related]

  • 18. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
    Spires TL, Grote HE, Garry S, Cordery PM, Van Dellen A, Blakemore C, Hannan AJ.
    Eur J Neurosci; 2004 May 12; 19(10):2799-807. PubMed ID: 15147313
    [Abstract] [Full Text] [Related]

  • 19. Progressive CAG expansion in the brain of a novel R6/1-89Q mouse model of Huntington's disease with delayed phenotypic onset.
    Vatsavayai SC, Dallérac GM, Milnerwood AJ, Cummings DM, Rezaie P, Murphy KP, Hirst MC.
    Brain Res Bull; 2007 Apr 30; 72(2-3):98-102. PubMed ID: 17352932
    [Abstract] [Full Text] [Related]

  • 20. Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy.
    Sawiak SJ, Wood NI, Morton AJ.
    J Huntingtons Dis; 2016 Oct 01; 5(3):271-283. PubMed ID: 27662335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.